1. EPWORTH Knowedge Bank
  2. Academic & Clinical
  3. Cancer Services
Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2012
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarrop, Sean-
dc.contributor.authorPrince, Miles-
dc.contributor.othervan der Weyden, Carrie-
dc.date.accessioned2021-07-30T03:22:54Z-
dc.date.available2021-07-30T03:22:54Z-
dc.date.issued2020-09-
dc.identifier.citationLeuk Lymphoma . 2020 Sep;61(9):2031-2033en_US
dc.identifier.issn1029-2403en_US
dc.identifier.urihttp://hdl.handle.net/11434/2012-
dc.description.abstractCommentary regarding the treatment of angioimmunoblastic T-cell lymphoma with pralatrexate following failure of first line therapy.en_US
dc.publisherTaylor & Francisen_US
dc.subjectPeripheral T-cell Lymphomaen_US
dc.subjectPTCLen_US
dc.subjectTreatmenten_US
dc.subjectTreatment Refactorinessen_US
dc.subjectPralatrexateen_US
dc.subjectEfficacyen_US
dc.subjectCancer Services Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titlePralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1080/10428194.2020.1795164en_US
dc.identifier.journaltitleLeukemia & Lymphomaen_US
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/32729765/en_US
dc.description.affiliatesDivision of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.en_US
dc.description.affiliatesSir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.en_US
dc.description.affiliatesMonash University, Melbourne, Australia.en_US
dc.type.contenttypeTexten_US
Appears in Collections:Cancer Services

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.